Race Oncology Limited (ASX:RAC)

Race Oncology Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	18.78	17.19	21.52	33.54	9.32	1.73
Cash & Short-Term Investments	18.78	17.19	21.52	33.54	9.32	1.73
Cash Growth	36.94%	-20.13%	-35.84%	259.79%	438.63%	75.05%
Other Receivables	-	0.11	1.7	0.06	0.13	0.05
Receivables	0.04	0.11	1.7	0.06	0.13	0.05
Prepaid Expenses	0.18	0.12	0.32	0.55	1.14	0.03
Other Current Assets	-	-	-	-	-	0.18
Total Current Assets	19	17.42	23.54	34.15	10.59	2
Other Intangible Assets	2.67	2.81	3.09	3.37	3.66	3.94
Total Assets	21.67	20.23	26.64	37.52	14.25	5.93
Accounts Payable	0.49	1.2	0.64	0.83	0.31	0.13
Accrued Expenses	0.44	0.67	0.51	0.58	0.21	0.11
Total Current Liabilities	0.92	1.87	1.15	1.42	0.52	0.24
Other Long-Term Liabilities	0.03	0.05	-	-	-	-
Total Liabilities	0.96	1.92	1.15	1.42	0.52	0.24
Common Stock	68.45	66.95	61.71	62.02	31.5	19.66
Retained Earnings	-56.92	-57.42	-43.6	-33.68	-22.47	-15.77
Comprehensive Income & Other	9.18	8.78	7.38	7.77	4.69	1.8
Shareholders' Equity	20.72	18.31	25.49	36.11	13.72	5.69
Total Liabilities & Equity	21.67	20.23	26.64	37.52	14.25	5.93
Net Cash (Debt)	18.78	17.19	21.52	33.54	9.32	1.73
Net Cash Growth	36.94%	-20.13%	-35.84%	259.79%	438.63%	75.05%
Net Cash Per Share	0.11	0.10	0.13	0.22	0.07	0.02
Filing Date Shares Outstanding	173.71	170.39	163.07	159.52	144.4	122.77
Total Common Shares Outstanding	173.71	170.3	163.07	159.52	143.65	116.45
Working Capital	18.08	15.55	22.39	32.73	10.07	1.75
Book Value Per Share	0.12	0.11	0.16	0.23	0.10	0.05
Tangible Book Value	18.04	15.5	22.39	32.73	10.07	1.75
Tangible Book Value Per Share	0.10	0.09	0.14	0.21	0.07	0.02

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.